Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alcon Plans PMA Submission In 2011 For Presbyopia/Toric Lens

This article was originally published in The Gray Sheet

Executive Summary

Alcon plans to submit a PMA in 2011 for an AcrySof IQ ReSTOR Toric lens for presbyopia and astigmatism correction, the company reported during its July 27 second-quarter earnings call

You may also be interested in...



Ophthalmic Panel To Eye Alcon’s AcrySof IQ Restor Multifocal IOL

FDA’s ophthalmic devices advisory panel plans to meet on Nov. 14 to assess Alcon Laboratories’ PMA application for its AcrySof IQ Restor multifocal toric posterior chamber intraocular lens.

Alcon To Launch LenSx Cataract Surgery Laser In Q4 Following Acquisition

Alcon will launch a femtosecond laser system for cataract surgery in the fourth quarter after acquiring technology developer LenSx Lasers

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.

Topics

UsernamePublicRestriction

Register

MT029185

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel